Evaluation of the Effects of Green Tea (Camellia sinensis) on Markers of Liver Function and Liver Histology in Wistar Rats
Faith Onyedikachi Ogar
Department of Pharmacology, Faculty of Basic Clinical Sciences, University of Port Harcourt, Port Harcourt, Rivers State, Nigeria.
Victor Tamunotonye Ibubeleye *
Department of Pharmacology, Faculty of Basic Clinical Sciences, University of Port Harcourt, Port Harcourt, Rivers State, Nigeria.
Precious Ojo Uahomo
Department of Biomedical Technology, School of Science Laboratory Technology, University of Port Harcourt, Port Harcourt, Rivers State, Nigeria.
Nwibana Barisuka Kofii
School of Medical Laboratory Science, Rivers State College of Health Science and Management Technology, Port Harcourt, Rivers State, Nigeria.
*Author to whom correspondence should be addressed.
Abstract
Background: Green tea is rich in flavonoids and catechins, compounds reported to have antioxidant, anti-inflammatory, and anticancer properties. However, there is a need to evaluate the effects of green tea on vital organs like the liver. This study aimed to investigate the effects of Camellia sinensis on markers of liver function, and liver histology in Wistar rats.
Methods: Forty-eight adult male Wistar rats were divided into four equal groups and orally administered 250mg/kg, 500mg/kg and 1000mg/kg of Camellia sinensis extract or 1ml of distilled water for up to 28 days. AST, ALT, ALP, TP, ALB, TB, and CB levels were measured at various time points. Effect on liver histology was also assessed using haematoxylin and eosin staining. Results: Camellia sinensis had varying effects on biomarkers of liver injury in a dose-dependent manner. Higher doses (500mg/kg and 1000mg/kg) of Camellia sinensis led to significant increases in AST, ALT, and ALP levels when consumed for up to 21 days. TP and ALB levels were not significantly altered. TB levels significantly increased in the highest dose group while CB levels did not significantly change at any time point studied. Also, higher doses of Camellia sinensis were associated with the development of fatty liver and mild inflammation from the histology. Conclusion: Camellia sinensis extract at low dose may not be harmful to the liver, however, the potential toxicity of green tea on the liver (at higher doses) should be further studied. Moderate use of green tea is therefore, recommended to ensure its safe and beneficial effects on liver health.
Keywords: Green tea, Camellia sinensis, liver function markers, toxicity, histology
How to Cite
References
Graham HN. Green tea composition, consumption, and polyphenol chemistry. Preventive Medicine. 1992;21(3):334-350.
Cabrera C, Artacho R, Giménez R. Beneficial effects of green tea- A review. Journal of the American College of Nutrition. 2006;25(2):79-99.
Sharma V, Singh R, Bhardwaj TR et al. Therapeutic potential of green tea catechins in treating diabetic cardiomyopathy. Current Drug Targets. 2020;21(1):91-101.
Yang CS, Wang ZY, Xu Y. Mechanisms of cancer prevention by tea polyphenols. In: Li J, Aggarwal BB, Shishodia S, editors. Asian Pacific Journal of Cancer Prevention. World Scientific Publishing Co. 2019;10.
Ogar FO, Georgewill OA, & Ibubeleye VT. Toxicological Effect of Green Tea (Camelia sinensis) on Haematological Parameters in Wistar Rats. Asian Journal of Research in Medical and Pharmaceutical Sciences. 2023;12(3):39–45.
Mbuthia KS, Mireji PO, Ngure RM et al. Tea (Camellia sinensis) infusions ameliorate cancer in 4TI metastatic breast cancer model. BMC complementary and alternative medicine. 2017;17(1):202.
Available:https://doi.org/10.1186/s12906-017-1683-6
Liu Y, Wang X, Chen Q et al. Camellia sinensis and Litsea coreana ameliorate intestinal inflammation and modulate gut microbiota in dextran sulfate sodium-induced colitis mice. Molecular nutrition & food research. 2020;64(6):e1900943.
Available:https://doi.org/10.1002/mnfr.201900943
Santos EL, Maia G, Araruna MK et al. Green tea extract-rich in epigallocatechin gallate and catechins-protects against liver injury through antioxidant and anti-inflammatory mechanisms. Journal of Functional Foods. 2015;19:593-605.
Roy S, Ahmed F, Banik P et al. Exploring the hepato-protective effects of green tea. BioMed Research International. 2017; 2017:1-13.
Lala V, Zubair M, Minter DA. Liver function tests. In: StatPearls [Internet]. StatPearls Publishing; 2023.
Lee SJ, Ahn EK, Lee YJ, et al. Modulatory effects of green tea catechins on hepatic drug-metabolizing enzymes in rats administered an aminopyrine cocktail. Cancer Letters. 2005;220(1):107-113.
Sharma V, Sood R, Manhas RK, et al. Hepatoprotective effect of ethanolic extract of allium wallichii on antitubercular drugs induced hepatotoxicity in experimental animals. Journal of Traditional and Complementary Medicine. 2018;8(3):432-439.
Maronpot RR. Liver: Anatomy, histology, and histopathology. Toxicologic Pathology. 2015;43(6):705-715.
Mazzanti G, Menniti-Ippolito F, Moro PA, et al. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. European Journal of Clinical Pharmacology. 2009;65(4):331-341.
Sae-Tan S, Grove KA, Lambert JD. Weight regain prevention. Current Obesity Reports. 2019;8(2):147-154.
Bruce RD. The Bruce treadmill test: A noninvasive procedure for the assessment of cardiovascular disease. JAMA. 1985;250(10):1982-1987.
Uahomo PO, Isirima JC. Antidiarrheal properties of aqueous leaf extract of Cyathula prostrata on castor oil-induced diarrhoea in Wistar rats. International Journal of Pharmaceutical Research and Applications. 2022;7(4):1679-1692.
Ibekwe VC, Nwobodo E, Onyeze GOC. Effect of ethanolic leaf extract of Ocimum gratissimum on some marker enzymes in albino rats. African Journal of Biotechnology. 2007;6(11):1347-1352.
Haussament AJ. Alkaline phosphatase. In: Bergmeyer HU, editor. Methods of Enzymatic Analysis. 2nd ed. Academic Press; 1977.
Xing L, Zhang H, Qi R, Tsao R, Mine Y. Recent advances in the understanding of the health benefits and molecular mechanisms associated with green tea polyphenols. Journal of agricultural and food chemistry. 2019;67(4):1029-1043.
Shareef SH, Ibrahim IAA, Alzahrani AR, Al-Medhtiy MH, Abdulla MA. Hepatoprotective effects of methanolic extract of green tea against Thioacetamide-Induced liver injury in Sprague Dawley rats. Saudi journal of biological sciences. 2022; 29(1):564-573.
Mahmoodi M, Hosseini R, Kazemi A, et al. Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized clinical trials. Phytotherapy research. 2020;34(7):1587-1598.
Opuwari C, Monsees T. Green tea consumption increases sperm concentration and viability in male rats and is safe for reproductive, liver and kidney health. Scientific reports. 2020;10(1): 15269.
Hayakawa S, Ohishi T, Miyoshi N, Oishi Y, Nakamura Y, Isemura M. Anti-cancer effects of green tea epigallocatechin-3-gallate and coffee chlorogenic acid. Molecules. 2020;25(19):4553.
Li M, Duan Y, Wang Y, et al. The effect of green green tea consumption on body mass index, lipoprotein, liver enzymes, and liver cancer: An updated systemic review incorporating a meta-analysis. Critical Reviews in Food Science and Nutrition. 2022:1-9.
Xu XY, Zheng J, Meng JM, et al. Effects of food processing on in vivo antioxidant and hepatoprotective properties of green tea extracts. Antioxidants. 2019;8(12):572.
Tokofai BM, Idoh K, Oke OE, Agbonon A. Hepatoprotective effects of Vernonia amygdalina (Astereaceae) extract on CCl4-induced liver injury in broiler chickens. Animals. 2021;11(12):3371.
Dey P, Bruno RS. Green tea catechins and nonalcoholic fatty liver disease. In: Dietary Supplements with Antioxidant Activity: Understanding Mechanisms and Potential Health Benefits; 2023.
Al-Salmi FA, Hamza RZ, El-Shenawy NS. The interaction of zinc oxide/green tea extract complex nanoparticles and its effect on monosodium glutamate toxicity in liver of rats. Current Pharmaceutical Biotechnology. 2019;20(6):465-475.
Oketch-Rabah HA, Roe AL, Rider CV, et al. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts. Toxicology reports. 2020;7:386-402.
Abe S, Inoue M. Green tea and cancer and cardiometabolic diseases: a review of the current epidemiological evidence. European journal of clinical nutrition. 2021;75(6):865-876.
Yin X, Yang J, Li T et al. The effect of green tea intake on risk of liver disease: A meta analysis. International journal of clinical and experimental medicine. 2015; 8(6):8339-8346.
Zamani M, Kelishadi MR, Ashtary-Larky D, et al. The effects of green tea supplementation on cardiovascular risk factors: A systematic review and meta-analysis. Frontiers in Nutrition. 2023;9:1084455.
Shimizu Y, Inoue H, Ohba Y, et al. Green tea extract intake during Liver Cancer Progression in Mice Attenuates the Increase in Insulin Resistance along with the Attenuation of Hepatic Steatosis and Changes in Gut Microbiota. J Clin Biochem Nutr. 2020;66(1):31-41.
Abeywickrama HM, Sung B, Prasad S, et al. Effects of green tea extract on markers of liver function and liver histology in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. Pharm Res. 2016;33(12):2978-2987.
Sajjad F, Minhas LA. Effects of Green Tea (Camellia sinensis) on Liver Function Tests of Mice on High Fat Diet. Pakistan Journal of Medical & Health Sciences. 2014; 8(3):550-553.
EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), Younes M, Aggett P, et al. Scientific opinion on the safety of green tea catechins. EFSA journal. European Food Safety Authority. 2018;16(4):e05239.
Lodhi P, Tandan N, Singh N, Kumar D, Kumar M. Camellia sinensis (L.) kuntze extract ameliorates chronic ethanol-induced hepatotoxicity in albino rats. Evidence-based complementary and alternative medicine: eCAM. 2014;2014: 787153.
National institute of diabetes and digestive and kidney diseases. Green Tea. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD).
Bedrood Z, Rameshrad M, Hosseinzadeh H. Toxicological effects of Camellia sinensis (green tea): A review. Phytotherapy Research. 2018;32(7):1163-1180.
Palacio Sánchez E, Ribero Vargas ME, Restrepo Gutiérrez JC. Hepatotoxicity due to green tea consumption (Camellia sinensis): A review. Revista colombiana de Gastroenterología. 2013;28(1):46-52.
Jimenez-Saenz M, Martinez-Sanchez M del C. Camellia sinensis liver toxicity. Journal of Hepatology. 2007;47(2):297–298.
Donata Grajecki, Alexandru Ogica, Olaf Boenisch, Peter Hübener, Stefan Kluge. Green tea extract–associated acute liver injury: Case report and review. Clinical Liver Disease. 2022;20:181–187.
Kanzler S, Rix A, Czigany Z, et al. Recommendation for severity assessment following liver resection and liver transplantation in rats: Part I. Laboratory Animals. 2016;50(6):459-467.
Mazzanti G, Di Sotto A, Vitalone A. Hepatotoxicity of green tea: an update. Archives of toxicology. 2015;89(8):1175–1191.
Sánchez M, González-Burgos E, Iglesias I, Lozano R, Gómez-Serranillos MP. The Pharmacological Activity of Camellia sinensis (L.) Kuntze on Metabolic and Endocrine Disorders: A Systematic Review. Biomolecules. 2020;10(4):603.
Sengottuvelu S, Duraisami S, Nandhakumar J, Duraisami R, Vasudevan M. Hepatoprotective activity of Camellia sinensis and its possible mechanism of action. IJPT. 2008;7:9-14.
Bonkovsky HL. Hepatotoxicity Associated with Supplements Containing Chinese Green Tea (Camellia sinensis). Annals of Internal Medicine. 2006;144(1):68.
Ting Li, Yuxin Wang, Yan Fang, et al. Longjing green tea (Camellia sinensis) extract dose-dependently influences intestinal barrier and liver inflammation in autoimmune hepatitis. Journal of Functional Foods. 2023;107:105623.